TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Return 18.15%
This Quarter Return
+4.56%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.67B
AUM Growth
+$41.2M
Cap. Flow
-$9.43M
Cap. Flow %
-0.35%
Top 10 Hldgs %
35.39%
Holding
233
New
11
Increased
50
Reduced
32
Closed
29

Top Buys

1
ABBV icon
AbbVie
ABBV
$29.9M
2
ILMN icon
Illumina
ILMN
$20.5M
3
STE icon
Steris
STE
$20.4M
4
SGEN
Seagen Inc. Common Stock
SGEN
$18.9M
5
HUM icon
Humana
HUM
$15.5M

Top Sells

1
JNJ icon
Johnson & Johnson
JNJ
$42.2M
2
TMO icon
Thermo Fisher Scientific
TMO
$33.8M
3
UNH icon
UnitedHealth
UNH
$29.4M
4
IMMU
Immunomedics Inc
IMMU
$23.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
$20.7M

Sector Composition

1 Healthcare 95.21%
2 Real Estate 2.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XNCR icon
101
Xencor
XNCR
$586M
$5.75M 0.22%
148,231
– –
SYNH
102
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$5.74M 0.22%
108,001
– –
FOLD icon
103
Amicus Therapeutics
FOLD
$2.42B
$5.73M 0.21%
405,626
+68,642
+20% +$969K
A icon
104
Agilent Technologies
A
$36B
$5.3M 0.2%
52,525
– –
ALLK
105
DELISTED
Allakos
ALLK
$5.25M 0.2%
64,397
– –
BCEL
106
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$4.92M 0.18%
352,424
– –
RVTY icon
107
Revvity
RVTY
$9.8B
$4.83M 0.18%
38,494
– –
AMED
108
DELISTED
Amedisys
AMED
$4.59M 0.17%
19,395
– –
BLUE
109
DELISTED
bluebird bio
BLUE
$4.54M 0.17%
6,500
– –
AUPH icon
110
Aurinia Pharmaceuticals
AUPH
$1.6B
$4.43M 0.17%
300,611
+209,823
+231% +$3.09M
TBPH icon
111
Theravance Biopharma
TBPH
$690M
$4.41M 0.17%
298,470
+69,634
+30% +$1.03M
NKTR icon
112
Nektar Therapeutics
NKTR
$614M
$4.36M 0.16%
17,539
– –
DOC icon
113
Healthpeak Properties
DOC
$12.3B
$4.08M 0.15%
150,392
– –
GBT
114
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.96M 0.15%
71,759
– –
SNN icon
115
Smith & Nephew
SNN
$16.4B
$3.89M 0.15%
99,560
– –
ACHC icon
116
Acadia Healthcare
ACHC
$2.18B
$3.87M 0.14%
131,200
– –
TAK icon
117
Takeda Pharmaceutical
TAK
$48.2B
$3.75M 0.14%
210,146
– –
CHRS icon
118
Coherus Oncology, Inc. Common Stock
CHRS
$155M
$3.73M 0.14%
203,103
– –
AMRN
119
Amarin Corp
AMRN
$305M
$3.58M 0.13%
42,479
– –
ABMD
120
DELISTED
Abiomed Inc
ABMD
$3.38M 0.13%
12,212
-3,582
-23% -$992K
BMY.RT
121
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$3.32M 0.12%
1,473,710
– –
ALGN icon
122
Align Technology
ALGN
$9.71B
$3.29M 0.12%
10,041
– –
KRTX
123
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.23M 0.12%
41,827
+11,954
+40% +$924K
ICPT
124
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.2M 0.12%
77,067
– –
ARWR icon
125
Arrowhead Research
ARWR
$3.79B
$3.19M 0.12%
74,186
– –
3 4
5
6 7